Innovative Cellular Therapeutics Announces Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
May 08, 2019 08:00 ET
|
Innovative Cellular Therapeutics
ICT’s lead “armored” CAR-T program, ICTCAR014, demonstrated responses in two patients treated for refractory diffuse large B-cell lymphoma (DLBCL) in an investigator-sponsored clinical trial in China;...
斯丹赛生物技术有限公司 Innovative Cellular Therapeutics 宣佈圓滿完成與 FDA 的臨床試驗審請前（Pre-IND）會議
April 09, 2019 21:00 ET
|
Innovative Cellular Therapeutics
中國上海和馬里蘭州羅克維爾, April 10, 2019 (GLOBE NEWSWIRE) -- 斯丹赛生物技术有限公司 (Innovative Cellu lar Therapeutics, ICT）是一間生物技術公司，主力開發治療癌症的細胞免疫療法。該公司在今天宣布與美國食品和藥物管理局（FDA）的臨床試驗審查前會議﹙研究性新藥﹚已圓滿結束。在會議上，FDA 就 ICT...
斯丹赛生物技术有限公司宣布圆满完成与FDA的新药临床试验申请前（Pre-IND）会议
April 09, 2019 21:00 ET
|
Innovative Cellular Therapeutics
中国上海及美国马里兰州罗克维尔, April 10, 2019 (GLOBE NEWSWIRE) -- 斯丹赛生物技术有限公司（Innovative Cellular...
Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA
April 09, 2019 21:00 ET
|
Innovative Cellular Therapeutics
SHANGHAI, China and ROCKVILLE, Md., April 09, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing cellular immunotherapies for the treatment of...
Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA
March 19, 2019 08:00 ET
|
Innovative Cellular Therapeutics
ROCKVILLE, Md., March 19, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing cellular immunotherapies for the treatment of cancer, today announced it...
Innovative Cellular Therapeutics Announces Opening of U.S. Office and Appointment of New Members to Executive Leadership Team
March 06, 2019 17:00 ET
|
Innovative Cellular Therapeutics
ROCKVILLE, Md., March 06, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing cellular immunotherapies for the treatment of cancer, today announced...